Niranjan Y. Sardesai
Company: Geneos Therapeutics
Job title: Chief Executive Officer
Seminars:
Personalized Therapeutics Cancer Vaccines for Treating Advanced Cancer – Efficacy in Liver Cancer 10:00 am
Utilizing DNA-based cancer vaccines that can encode for up to 40 neoantigens to achieve powerful T cell response Employing personalized cancer vaccines in an advanced cancer setting to shrink tumors Exploring correlative biomarker analyses to understand vaccine efficacyRead more
day: Conference Day One
Panel Discussion:Examining the Route of Personalized Cancer Vaccines From a Range of Modalities Through the Clinic to Get Effective Therapies to Patients Faster 9:30 am
Uncovering how successful trials are in selecting patients and achieving clinical efficacy Understanding the importance of durability and half-life of vaccines in patients for a swift journey through the clinic Navigating the regulatory frameworks for personalized medicine to ensure success post-approvalRead more
day: Conference Day Two